FDA approves Roche’s CD20 antibody Gazyva for lupus nephritisnews2025-10-20T05:00:46+00:00October 20th, 2025|Endpoints News|
Meet the first nine recipients of the FDA’s new vouchernews2025-10-17T19:31:44+00:00October 17th, 2025|Endpoints News|
CHMP rejects Sanofi’s Rezurock over clinical data issues, but recommends Wayrilznews2025-10-17T14:44:13+00:00October 17th, 2025|Endpoints News|
Thirona Receives FDA Clearance for LungQ® 4 Software, Expanding AI-Powered Capabilities in Lung Image Analysis for the U.S. Marketnews2025-10-16T16:15:15+00:00October 16th, 2025|Medical Device News Magazine|
Ex-FDA leaders take helm of new consultancy, discuss the state of the agencynews2025-10-15T17:45:48+00:00October 15th, 2025|Endpoints News|
Former FDA deputy Bumpus to lead Charles River’s new scientific advisory boardnews2025-10-15T12:08:48+00:00October 15th, 2025|Endpoints News|
Krystal Biotech wins second-ever FDA platform designation for viral vectornews2025-10-14T17:38:16+00:00October 14th, 2025|Endpoints News|
Three big questions ahead of third-quarter pharma earningsnews2025-10-13T20:09:50+00:00October 13th, 2025|Endpoints News|
FDA on pace for lowest number of new drug approvals since 2022news2025-10-13T19:30:48+00:00October 13th, 2025|Endpoints News|
FDA hands OAI classification to Novo Nordisk’s troubled Indiana sitenews2025-10-13T15:38:49+00:00October 13th, 2025|Endpoints News|
